Commentary on “Asymmetric Dimethylarginine as a Potential Biomarker for Cardiovascular Risk Assessment in Long-Standing Type 1 Diabetes Mellitus”
Asymmetric dimethylarginine (ADMA) has been discussed as a potential biomarker of cardiovascular risk, but its interpretation in type 1 diabetes mellitus (T1DM) remains context-dependent. In commenting on the recent study by Chausheva et al., we suggest that the findings should be interpreted cautio...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivano-Frankivsk National Medical University
2026-04-01
|
| シリーズ: | Galician Medical Journal |
| 主題: | |
| オンライン･アクセス: | https://ifnmujournal.com/gmj/article/view/2403 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|